The relationship between social anxiety disorder and alcohol use disorders: A critical review

2005 ◽  
Vol 25 (6) ◽  
pp. 734-760 ◽  
Author(s):  
Eric P. Morris ◽  
Sherry H. Stewart ◽  
Lindsay S. Ham
2021 ◽  
Vol 85 (2) ◽  
pp. 100-122
Author(s):  
Mirjana Subotic-Kerry ◽  
Andrew J. Baillie ◽  
Lexine A. Stapinski ◽  
Maree J. Abbott ◽  
Jo MacDonald ◽  
...  

Comorbid social anxiety and alcohol use disorders (SAD-AUD) in the community and the complex interactions that occur between these disorders have emerged as a significant clinical, public health, and research issue. The authors examined (a) the rates of comorbid SAD-AUD, (b) the impact of comorbid SAD-AUD on outcomes targeting social anxiety disorder, and (c) the effect of pretreatment alcohol consumption and alcohol use before, during, and after social situations on a composite measure of social anxiety in 172 adults presenting with social anxiety disorder. There was low incidence of AUD in this sample of individuals with SAD. Results indicated that alcohol consumption did not lead to worse social anxiety symptoms; however, alcohol use before and during social situations was associated with more severe social anxiety symptoms. These findings suggest that the function of alcohol use may be more important than the overall level of alcohol use and has implications for treatment.


2017 ◽  
Vol 7 (11) ◽  
pp. 241-247 ◽  
Author(s):  
Ahmet Koyuncu ◽  
Fahri Çelebi ◽  
Erhan Ertekin ◽  
Burcu Ece Kök ◽  
Raşit Tükel

Background: The relationship between social anxiety disorder (SAD) and attention-deficit/hyperactivity disorder (ADHD) is a subject which has recently become a topic of interest for research. Methods: In this study, 20 patients with comorbid SAD and adult ADHD who were treated with extended-release methylphenidate monotherapy were evaluated retrospectively. Results: Clinical response for both ADHD and SAD symptoms was observed in 17 of 20 patients. Overall, one patient did not respond to treatment and two patients dropped out of treatment at the beginning due to adverse effects. Conclusion: Extended-release methylphenidate improved both SAD and ADHD symptoms and was generally well tolerated. Further studies are required to investigate the relationship between SAD and ADHD.


Sign in / Sign up

Export Citation Format

Share Document